ArticleIrish veterinary journal2026
Plasma and urinary exposure of cannabidiol and cannabidiolic acid in horses following consumption of contaminated feed.
Article in Irish veterinary journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCannabidiol (CBD) and cannabidiolic acid (CBDA) are non-psychoactive cannabinoids naturally present in hemp-derived products. While these compounds are prohibited during equine competition, horses may be inadvertently exposed through contaminated feed. Data describing systemic and urinary exposure to CBD and CBDA following such low-dose, involuntary intake are limited. This study aimed to describe plasma and urine concentration-time profiles of CBD and CBDA in horses after consumption of experimentally contaminated feed.
resultsTwelve Standardbred horses received feed containing low doses (10-15 mg) of either CBD or CBDA twice daily for three days. Neither compound was detected in pre-administration samples. Following exposure, CBD was only sporadically quantifiable in plasma, whereas CBDA was detected in plasma from most horses for up to 48 h. In urine, both cannabinoids were quantifiable in all horses, with CBDA consistently present at higher concentrations and for longer durations than CBD. Maximum observed urinary concentrations were markedly higher for CBDA than for CBD. Considerable inter-individual variability was observed in both plasma and urine concentrations. Neither CBD nor CBDA was detected in plasma or urine for more than four days. Overall, systemic exposure following feed contamination was low compared with doses reported to produce therapeutic effects in horses or other species.
conclusionsLow-dose oral exposure to CBD and CBDA, mimicking feed contamination, can result in detectable concentrations of cannabinoids in equine plasma and urine, with CBDA representing the predominant analyte. Although the study was not designed to establish detection times and analytical sensitivity may differ from routine doping control, the findings demonstrate that inadvertent exposure through feed may lead to measurable cannabinoid concentrations despite doses well below those associated with reported pharmacological effects. These results highlight the importance of awareness of potential contamination sources and cautious interpretation of low-level cannabinoid findings in equine biological samples.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.